ORIC
Price:
$8.27
Market Cap:
$856.09M
ORIC Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative treatments for cancer patients across the United States. The company's pipeline includes several key clinical-stage drug candidates. ORIC-533 is an oral small molecule designed to inhibit CD73, addressing resistance to both chemotherapy and immunotherapy. Another candidate, ORIC-944, is an allosteric inhibitor targeting the polycomb repressive complex 2, specifically for the treatment of prostate cancer. Furthermore, ORIC-114 is a brain-penetrant, orally administered, irreversible inhibitor crafted to precisely target epidermal growth factor receptor (EGFR) and hum...[Read more]
Industry
Biotechnology
IPO Date
2020-04-24
Stock Exchange
NASDAQ
Ticker
ORIC
According to ORIC Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 16.33. This represents a change of 6.68% compared to the average of 15.31 of the last 4 quarters.
The mean historical Current Ratio of ORIC Pharmaceuticals, Inc. over the last ten years is 15.71. The current 16.33 Current Ratio has changed 10.29% with respect to the historical average. Over the past ten years (40 quarters), ORIC's Current Ratio was at its highest in in the March 2021 quarter at 36.49. The Current Ratio was at its lowest in in the March 2019 quarter at 0.
Average
15.71
Median
14.13
Minimum
10.20
Maximum
32.96
Discovering the peaks and valleys of ORIC Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 96.07%
Maximum Annual Current Ratio = 32.96
Minimum Annual Increase = -51.83%
Minimum Annual Current Ratio = 10.20
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 14.13 | 33.86% |
| 2024 | 10.56 | 1.57% |
| 2023 | 10.39 | -24.02% |
| 2022 | 13.68 | -13.85% |
| 2021 | 15.87 | -51.83% |
| 2020 | 32.96 | 96.07% |
| 2019 | 16.81 | -0.20% |
| 2018 | 16.84 | 65.20% |
The current Current Ratio of ORIC Pharmaceuticals, Inc. (ORIC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
11.69
5-year avg
12.93
10-year avg
15.71
ORIC Pharmaceuticals, Inc.’s Current Ratio is less than Amylyx Pharmaceuticals, Inc. (17.85), less than Relay Therapeutics, Inc. (22.13), greater than Precigen, Inc. (4.82), greater than Nektar Therapeutics (10.21), greater than Inhibrx Biosciences, Inc. (6.46), greater than Syndax Pharmaceuticals, Inc. (5.47), less than Terns Pharmaceuticals, Inc. (62.41), less than Enliven Therapeutics, Inc. (40.32), less than Tourmaline Bio, Inc. (24.68), greater than Atai Beckley Inc. (10.02),
| Company | Current Ratio | Market cap |
|---|---|---|
| 17.85 | $1.21B | |
| 22.13 | $2.59B | |
| 4.82 | $1.34B | |
| 10.21 | $1.16B | |
| 6.46 | $1.35B | |
| 5.47 | $1.62B | |
| 62.41 | $4.77B | |
| 40.32 | $2.81B | |
| 24.68 | $1.23B | |
| 10.02 | $1.44B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ORIC Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ORIC Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is ORIC Pharmaceuticals, Inc.'s Current Ratio?
How is the Current Ratio calculated for ORIC Pharmaceuticals, Inc. (ORIC)?
What is the highest Current Ratio for ORIC Pharmaceuticals, Inc. (ORIC)?
What is the 3-year average Current Ratio for ORIC Pharmaceuticals, Inc. (ORIC)?
What is the 5-year average Current Ratio for ORIC Pharmaceuticals, Inc. (ORIC)?
How does the current Current Ratio for ORIC Pharmaceuticals, Inc. (ORIC) compare to its historical average?